Regencor, Inc.;Sanford Burnham Prebys Medical Discovery Institute
发明人:
Ruiz-Lozano, Pilar,Mercola, Mark,Wei, Ke
申请号：
AU2020204541
公开号：
AU2020204541A1
申请日:
2020.07.08
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020204541A120200730.pdf#####1003092278 ABSTRACT Provided herein, inter alia, are compositions and kits comprising epicardial-derived paracrine factors (such as, hypoglycosylated follistatin-like 1 (FSTL1)) for treating and repairing damage to cardiac tissue caused by cardiovascular disease, myocardial infarction (MI), other ischemic events, or cardiac-growth deficiency, as well as methods for using the same.
